|
시장보고서
상품코드
2126553
트랜스덕션 인핸서 시약 시장 : 제품 유형별, 벡터 유형별, 용도별, 최종사용자별, 지역별Transduction Enhancer Reagents Market, By Product Type, By Vector Type, By Application, By End User, By Geography |
||||||
트랜스덕션 인핸서 시약 시장은 2026년에 1억 1,950만 달러 규모가 될 것으로 추정되며, 2033년까지 2억 1,050만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 8.4%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 1억 1,950만 달러 |
| 과거 데이터 대상 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 8.40% | 2033년 시장 규모 예측: | 2억 1,050만 달러 |
트랜스덕션 인핸서 시약은 세포 생존율을 저해하지 않으면서 바이러스 입자와 세포막 간의 상호작용을 강화함으로써, 표적 세포에 대한 바이러스 벡터를 통한 유전자 도입 효율을 높이는 특수한 생화학 화합물입니다. 이 시약들은 바이러스에 의한 전이를 극대화하기 위해 유전자 치료, 세포 치료 및 분자 생물학 연구 분야에서 일상적으로 사용되고 있습니다.
세계 트랜스덕션 인핸서 시약 시장은 유전자 치료 및 세포 치료 파이프라인의 확대, 제조 인프라에 대한 투자 증가, 그리고 렌티바이러스 및 아데노연관바이러스(AAV) 벡터의 활용 확대에 힘입어 성장하고 있습니다. 주요 최종사용자로는 제약 회사, 생명공학 기업, CDMO, CRO 및 학술 기관이 포함됩니다. 한편, 폴리브렌, 프로타민 황산염 및 독자적인 차세대 강화제 등의 제품은 다양한 연구 및 치료 용도로 활용되고 있습니다.
시장 역학
세계 트랜스덕션 인핸서 시약 시장은 유전자 치료 및 세포 치료 개발의 급속한 진전, 렌티바이러스 및 AAV 벡터의 활용 확대, 유전체학, 유전자 변형, 재생 의학에 대한 투자 증가에 힘입어 성장하고 있습니다. 세포 및 유전자 치료의 제조 능력 강화와 전문 CDMO의 확장이 트랜스덕션 인핸서 시약 시장의 성장을 뒷받침할 것으로 예상됩니다.
그러나 트랜스덕션 인핸서 시약 시장의 성장은 독자적인 배합 제제의 높은 비용, 엄격한 규제 및 생물안전 규정, 그리고 일부 기존형 강화제에 수반되는 세포 독성 우려와 같은 요인에 의해 제약을 받고 있습니다. 그럼에도 불구하고, 1세대 배양 세포 및 줄기세포용 무독성, 무혈청, GMP 준수 강화제의 개발에는 큰 여지가 있습니다. 아시아태평양, 특히 중국, 한국, 인도에서의 유전자 치료 제조 확대 또한 전 세계 트랜스덕션 인핸서 시약 시장의 잠재적 성장 기회로 작용하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 규명하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음 매개변수(기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 트랜스덕션 인핸서 시약 시장의 주요 기업 개요를 작성하고 있습니다.
- 본 보고서에서 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 ‘세계 트랜스덕션 인핸서 시약 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 트랜스덕션 인핸서 시약 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 트랜스덕션 인핸서 시약 시장 : 제품 유형별, 2021-2033년
제5장 세계의 트랜스덕션 인핸서 시약 시장 : 벡터 유형별, 2021-2033년
제6장 세계의 트랜스덕션 인핸서 시약 시장 : 용도별, 2021-2033년
제7장 세계의 트랜스덕션 인핸서 시약 시장 : 최종사용자별, 2021-2033년
제8장 세계의 트랜스덕션 인핸서 시약 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고문헌 및 조사 방법
KSM 26.09.09Transduction Enhancer Reagents Market is estimated to be valued at USD 119.5 Mn in 2026 and is expected to reach USD 210.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 119.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.40% | 2033 Value Projection: | USD 210.5 Mn |
Transduction enhancer reagents are specialized biochemical compounds that improve the efficacy of viral vector-mediated gene delivery to target cells by enhancing the interaction between the viral particle and the cell membrane, without compromising the viability of the cell. They are routinely used in gene therapy, cell therapy and molecular biology research applications to maximize viral transduction.
The global transduction enhancer reagents market is driven by the increasing pipeline of gene and cell therapies, growing investments in manufacturing infrastructure, and increasing use of lentiviral and adeno-associated viral (AAV) vectors. Major end users include pharmaceutical and biotechnology companies, CDMOs, CROs, and academic institutions, whereas products such as polybrene, protamine sulfate, and proprietary next-generation enhancers serve a variety of research and therapeutic applications.
Market Dynamics
The global transduction enhancer reagents market is driven by rapid growth in the development of gene and cell therapy, increasing utilization of lentiviral and AAV vectors, increasing investment in genomics, gene modification, and regenerative medicine. Increasing capacity of cell and gene therapy manufacturing, and expansion of specialized CDMOs are expected to drive the transduction enhancer reagents market.
However, the growth of transduction enhancer reagents market is limited by factors such as high cost of proprietary formulations, strict regulatory and biosafety regulations, and cytotoxicity concerns associated with some conventional enhancers. Nevertheless, there is significant scope for development of non-toxic serum-free and GMP-compatible enhancers for primary and stem cells. Growth in gene therapy manufacturing in Asia-Pacific region, especially in China, South Korea, and India, is also a potential growth opportunity in the global transduction enhancer reagents market.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global transduction enhancer reagents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Takara Bio Inc., Sartorius AG, Bio-Rad Laboratories, Inc., Promega Corporation, Bio-Techne Corporation, GenScript Biotech Corporation, and OZ Biosciences SAS
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global transduction enhancer reagents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transduction enhancer reagents market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Polymer-based
- Peptide-based
- Lipid-based
- Others
- Vector Type Insights (Revenue, USD Mn, 2021 - 2033)
- Lentiviral
- Retroviral
- AAV
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Gene and Cell Therapies
- Drug Development and Research
- Vaccine Development
- Others
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharma and Biotech Firms
- Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs)
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Lonza Group Ltd.
- Takara Bio Inc.
- Sartorius AG
- Bio-Rad Laboratories, Inc.
- Promega Corporation
- Bio-Techne Corporation
- GenScript Biotech Corporation
- OZ Biosciences SAS
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Transduction Enhancer Reagents Market, By Product Type
- Global Transduction Enhancer Reagents Market, By Vector Type
- Global Transduction Enhancer Reagents Market, By Application
- Global Transduction Enhancer Reagents Market, By End User
- Global Transduction Enhancer Reagents Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Industry Trends
4. Global Transduction Enhancer Reagents Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Polymer-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Peptide-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lipid-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Transduction Enhancer Reagents Market, By Vector Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Lentiviral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retroviral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- AAV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Transduction Enhancer Reagents Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Gene and Cell Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Drug Development and Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vaccine Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Transduction Enhancer Reagents Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharma and Biotech Firms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Manufacturing Organizations (CMOs) and Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Transduction Enhancer Reagents Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Company Profile
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sartorius AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Techne Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- OZ Biosciences SAS
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
